FDA Inspection
Dorel Sandesc, MDDorel Sandesc, MD – FDA Inspection, Nov 1, 2013
Record Details
This FDA Inspection record concerns Dorel Sandesc, MD, with an inspection on November 1, 2013, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Company
- Dorel Sandesc, MD
- Inspection Date
- November 1, 2013
- Product Type
- Biologics
View Company Profile
ID · 016e14f0-1c0a-4072-b729-f78345ddca86
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 855604
- FDA center
- Biologics
- Project area
- Bioresearch Monitoring
FDA Citations
2- 21 CFR 312.60FD-1572, protocol compliance
- 21 CFR 312.62(b)Case history records- inadequate or inadequate
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Dorel Sandesc, MD
1| Date | Classification | Office | Project area |
|---|---|---|---|
| June 7, 2016 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
Other documents for Dorel Sandesc, MD
- FDA Inspection 974689 - 2016-06-07
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.